Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CISD2 | Q8N5K1 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17280435 | 0.90 | ELANE (0.30) | L3MBTL1ELANE | |
| SCHEMBL17364572 | 0.88 | ALDH1A1 (0.30) | — | |
| SCHEMBL18828155 | 0.87 | CA1 (0.36) | L3MBTL1CA1CA2GAA | |
| SCHEMBL30252476 | 0.87 | CA1 (0.36) | L3MBTL1CA1CA2GAA | |
| SCHEMBL17280437 | 0.85 | ALDH1A1 (0.36) | GAAELANE | |
| SCHEMBL17277942 | 0.85 | APEX1 (0.34) | CA1CA2GAAELANE | |
| SCHEMBL17280444 | 0.85 | — | — | |
| SCHEMBL17280436 | 0.83 | MEN1 (0.32) | ELANE | |
| SCHEMBL18682925 | 0.83 | TNFRSF1A (0.34) | CA1CA2ELANE | |
| SCHEMBL17280447 | 0.81 | ALDH1A1 (0.36) | GAAELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9840524-B2 | Process for reducing the chlorine content of organomonophosphites using two solutions | EVONIK DEGUSSA GMBH (DE) | 2017-12-12 | — | — | US | disclosed |
| US-9840524-B2 | Process for reducing the chlorine content of organomonophosphites using two solutions | EVONIK DEGUSSA GMBH (DE) | 2017-12-12 | — | — | US | disclosed |
| US-9751904-B2 | Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine | EVONIK DEGUSSA GMBH (DE) | 2017-09-05 | — | — | US | disclosed |
| US-20170121355-A1 | PROCESS FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | EVONIK DEGUSSA GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-20170121355-A1 | PROCESS FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | EVONIK DEGUSSA GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-20170088570-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING DIMETHYLAMINOBUTANE, TRIETHYLAMINE OR TRIETHANOLAMINE | EVONIK DEGUSSA GMBH (DE) | 2017-03-30 | — | — | US | disclosed |
| EP-2947089-B1 | NOVEL MONOPHOSPHITE LIGANDS WITH A CARBONATE GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-08-24 | — | — | EP | disclosed |
| EP-2947090-B1 | NOVEL MONOPHOSPHITE LIGANDS WITH A TERTIARY BUTYLOXYCARBONYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2016-08-24 | — | — | EP | disclosed |
| US-9221850-B2 | Monophosphite ligands having a tert-butyloxycarbonyl group | EVONIK INDUSTRIES AG (DE) | 2015-12-29 | — | — | US | disclosed |
| US-9212195-B1 | Monophosphite ligands having a carbonate group | EVONIK INDUSTRIES AG (DE) | 2015-12-15 | — | — | US | disclosed |
| US-20150336988-A1 | NOVEL MONOPHOSPHITE LIGANDS HAVING A TERT-BUTYLOXYCARBONYL GROUP | EVONIK INDUSTRIES AG (DE) | 2015-11-26 | — | — | US | disclosed |
| WO-2015176929-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING DIMETHYLAMINOBUTANE, TRIETHYLAMINE OR TRIETHANOLAMINE | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | WO | disclosed |
| WO-2015176927-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | WO | disclosed |
| EP-2947090-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A TERTIARY BUTYLOXYCARBONYL GROUP | Evonik Industries AG (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947089-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A CARBONATE GROUP | Evonik Degussa GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121355-A1 | PROCESS FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | PHOSPHO1, PLCG2, PLCG1 | L3MBTL1 2733/4885CISD2 104/4885CA1 514/4885 |
| US-20150336988-A1 | NOVEL MONOPHOSPHITE LIGANDS HAVING A TERT-BUTYLOXYCARBONYL GROUP | TERF2, NUDT1, TERF2IP | L3MBTL1 681/4885CISD2 3285/4885CA1 4792/4885 |
| US-20170088570-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING DIMETHYLAMINOBUTANE, TRIETHYLAMINE OR TRIETHANOLAMINE | PHOSPHO1, SGMS2, SGMS1 | L3MBTL1 850/4885CISD2 161/4885CA1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.